WSGR logoWSGR logo
Jennifer Fang
Partner
Corporate
Boston

D617-598-7800

Download vCard
LinkedIn
Open PDF
  • A Recognized Practitioner

    Jennifer was recognized in the 2023 and 2024 editions of Chambers USA, Boston Magazine’s inaugural “Top Lawyers” list, and named a “Go-To Business Lawyer” by Massachusetts Lawyers Weekly.

  • Thought Leadership

    She serves on the General Counsel Advisory Board of the National Venture Capital Association.

  • Focus on Cutting-Edge Life Science Companies

    Jennifer helps a variety of start-ups and pre-IPO companies in the pharmaceutical, biotechnology, medical device and diagnostic industries, combining her legal expertise with her background in Biological Engineering.

Jennifer Fang is a partner in the Boston office of Wilson Sonsini Goodrich & Rosati. She helps innovative start-ups grow into successful enterprises by providing counsel to the founders, management teams, and boards and by handling the legal and strategic business issues and transactions that arise at each stage. She is experienced in negotiating and executing a variety of corporate transactions, including conversions, spinouts, debt and equity financings, public offerings, PIPEs, mergers and acquisitions, and joint ventures. She also counsels venture capital, growth capital, and strategic investors with respect to their investment transactions and their existing portfolio companies. Her practice focuses on companies that can improve patient lives and healthcare through innovations and advances, including in gene editing, cell therapy, novel therapeutics, synthetic biology, proteomics, diagnostics, bioinformatics, medical devices, and research and manufacturing tools and processes.

Jennifer has been recognized by various publications and organizations for her work in the life sciences industry. Chambers USA notes she is increasing recognized for her work advising emerging life sciences companies on a wide range of corporate matters, including financings, IPOs, and M&A. Jennifer was also honored with the 2022 “Best Under 40” award by the National Asian Pacific American Bar Association (NAPABA), which highlighted her work with growing start-ups to enterprises, and named a “Top Woman of Law” honoree by Massachusetts Lawyers Weekly.

She is also a frequent speaker on corporate and securities topics, such as company formation risks, equity compensation issues, angel and venture financing terms, and founder pitfalls, and currently serves on the General Counsel Advisory Board of the National Venture Capital Association.

Jennifer is co-chair of the firm’s Diversity, Equity, and Inclusion Committee and serves on the investment committee for the firm's affiliated fund, the WS Investment Company. She’s also a member of the firm’s Career Development Committee and the Boston office hiring committee. In her free time, she enjoys mentoring young lawyers, entrepreneurs, and investors in the local community.

Experience

Jennifer Fang is a partner in the Boston office of Wilson Sonsini Goodrich & Rosati. She helps innovative start-ups grow into successful enterprises by providing counsel to the founders, management teams, and boards and by handling the legal and strategic business issues and transactions that arise at each stage. She is experienced in negotiating and executing a variety of corporate transactions, including conversions, spinouts, debt and equity financings, public offerings, PIPEs, mergers and acquisitions, and joint ventures. She also counsels venture capital, growth capital, and strategic investors with respect to their investment transactions and their existing portfolio companies. Her practice focuses on companies that can improve patient lives and healthcare through innovations and advances, including in gene editing, cell therapy, novel therapeutics, synthetic biology, proteomics, diagnostics, bioinformatics, medical devices, and research and manufacturing tools and processes.

Jennifer has been recognized by various publications and organizations for her work in the life sciences industry. Chambers USA notes she is increasing recognized for her work advising emerging life sciences companies on a wide range of corporate matters, including financings, IPOs, and M&A. Jennifer was also honored with the 2022 “Best Under 40” award by the National Asian Pacific American Bar Association (NAPABA), which highlighted her work with growing start-ups to enterprises, and named a “Top Woman of Law” honoree by Massachusetts Lawyers Weekly.

She is also a frequent speaker on corporate and securities topics, such as company formation risks, equity compensation issues, angel and venture financing terms, and founder pitfalls, and currently serves on the General Counsel Advisory Board of the National Venture Capital Association.

Jennifer is co-chair of the firm’s Diversity, Equity, and Inclusion Committee and serves on the investment committee for the firm's affiliated fund, the WS Investment Company. She’s also a member of the firm’s Career Development Committee and the Boston office hiring committee. In her free time, she enjoys mentoring young lawyers, entrepreneurs, and investors in the local community.

Focus Areas
Recent Insights
Podcasts
NextGen VC Podcast Episode 9 - Exploring the Intersection of Biotech and Corporate VC with Danjuma Quarless
In this episode of the NextGen VC podcast, hosts Mike Hostetler and Jennifer Fang sit down with Danjuma Quarless from AbbVie Ventures to delve into the world of corporate venture capital. Danjuma shares insights on how corporate VCs like AbbVie differ from traditional VCs, particularly in the biotech and pharmaceutical industries. Listeners will learn about the strategic focus of AbbVie Ventures, the importance of scientific and competitive differentiation in securing investment, and the fluid communication within AbbVie's ecosystem. Danjuma also shares his personal journey from a research scientist to a venture capitalist, offering valuable advice for those looking to break into the venture capital space. The podcast also touches on the current trends in biotech, the challenges and opportunities in various regional ecosystems, and the importance of promoting diversity within the venture capital industry. Tune in to hear about the latest innovations in biotech, the differences in investment approaches between various regions, and how AbbVie Ventures aims to build communities and support underrepresented groups in the industry.
Learn More
News Articles
Jen Fang Named to Boston Magazine's 2024 Top Lawyers List
On November 25, 2024, Boston Magazine published its annual list of Top Lawyers, highlighting the top attorneys in a wide range of legal specialties in the region. This extensive guide was compiled after local lawyers were invited to nominate up to three peers within specific specialties. Boston Magazine reviewed the credentials based on the votes with an advisory board to make the final choices. Wilson Sonsini's Jennifer Fang was recognized in the guide for the fourth consecutive year.
Learn More
View All
Recent Events
Affiliated Programs
2024 Northern New England MedTech Conference & MedTech Collaborative Pitch Competition
On November 12th, Jennifer Fang will be a judge at the annual Live Pitch Competition. The Northern New England MedTech Conference (NNEMTC) is a two-day, in-person experience that brings together the MedTech Collaborative Pitch Competition and Northern New England MedTech Conference in one program.
Learn More
Affiliated Programs
American Cancer Society BrightEdge Entrepreneurs Pitch Event and Converge on Cancer Summit
Wilson Sonsini is proud to sponsor the ACS BrightEdge Entrepreneurs Pitch Event on October 28 and the ACS BrightEdge Converge on Cancer Summit on October 29. Firm partner Jennifer Fang will speak on the panel entitled "Fostering Founders and Entrepreneurs Across the Innovation Impasse" at the summit on Tuesday, October 29th. This is a private, by-invitation-only event.
Learn More
View All
WSGR logo
Copyright © 2024 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.